Home > PJ (current issue) > Leading article | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7350 p600
21 May 2005

This article
Reprint   Photocopy

PDF 45K, Acrobat Reader

Leading Article

Singing in unison

For once, the pharmacy bodies seem to be singing from the same song sheet. What they are singing about is the consultation carried out by the Medicines and Healthcare products Regulatory Agency and Department of Health on proposals to introduce independent prescribing for all UK pharmacists, which comes to an end next week.

The leading bodies approached by The Journal all draw the same conclusion that pharmacists should be able to prescribe from a full formulary and for any condition, provided they prescribe within their own areas of competence (p607).

This is the only realistic position to adopt. Community pharmacists are already experienced independent prescribers of any pharmacy medicine sold — after a customer describes a set of symptoms which the pharmacist does not believe requires a GP consultation for a prescription-only medicine. In addition, pharmacists involved in many of the minor ailments schemes, for example, are independently prescribing, as are, to some extent, those pharmacists who supply medicines under patient group directions.

Since many GPs opted out of their out-of-hours responsibilities in April and practices are now closed at weekends, there is an even greater imperative to give pharmacists the freedom to prescribe independently. Although, in theory, pharmacists are entitled to sell emergency supplies of prescription-only medicines (“Medicines, ethics and practice”, vol 28, July 2004, p12) it is not always easy for patients to obtain supplies this way. How much time and resources might be saved if patients knew that their local pharmacist would be able to help them promptly instead of, say, their having to go to the local accident and emergency department?

The limiting factor for all this will be pharmacists’ ability to be primary diagnosticians. Some specialist hospital pharmacists may have the opportunity and access to appropriate tests to develop the skills and expertise to be able to diagnose and prescribe within a particular clinical discipline. Community pharmacists, like GPs, are generalists and tend not to become involved in the management of complicated or tricky medical conditions. But in the way that medical consultants can make a primary diagnosis and the GP then prescribes the appropriate medicine, there is no reason why a GP cannot make the primary diagnosis and a pharmacist decide on the best medicines for a patient. There are training and clinical governance issues to be considered but, in this instance, independent prescribing in many ways is more straightforward than supplementary prescribing. If there is the will, a way should be found.

Back to Top


©The Pharmaceutical Journal